Nautilus Biotechnology, Inc. (NAUT): R&D Expense
$41.11M
Year ended 2025-12-31
$38.50M
Trailing 12 months to 2026-06-30
+3.0%
3-year compound annual growth
+27.0%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.11M | -18.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $50.48M | +6.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $47.25M | +25.4% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $37.67M | +28.3% | 2024-02-28, From 2022-01-01 |
| 2021-12-31 | $29.35M | +136.1% | 2023-02-23, From 2021-01-01 |
| 2020-12-31 | $12.43M | n/a | 2022-02-24, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | 2025-12-31 | $41.11M | -18.6% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $15.57M | +3.9% |
| Seer, Inc. (SEER) | 2025-12-31 | $43.87M | -13.3% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $221.04M | +66.3% |
| Quanterix Corp (QTRX) | 2025-12-31 | $35.92M | +15.6% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $8.82M | -15.2% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $36.47M | -7.4% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $13.60M | -6.8% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $11.37M | -54.1% |
Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗